UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Tag: lung cancer
Learn how this therapy can offer a critical second-line option for your stage 4 small cell lung cancer patients.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
Based on the results from a recent clinical trial, the guidelines for which patients should be screened for lung cancer may soon change.
UVA is recruiting highly skilled clinicians and active research scientists who are dedicated to discovering and utilizing enhanced diagnostic tools and advanced treatments for thoracic malignancies.
UVA has established the Comprehensive Lung Cancer Screening Program to identify those patients at elevated risk, diagnose lung cancer in its earliest stages and provide therapy when the disease is most treatable.